NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹2,176 Cr | ₹953 Cr | ₹546 Cr | ₹206 Cr | ₹284 Cr |
What is the latest Cash and Bank ratio of NATCO PHARMA ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹2,176 Cr |
| Mar2024 | ₹953 Cr |
| Mar2023 | ₹546 Cr |
| Mar2022 | ₹206 Cr |
| Mar2021 | ₹284 Cr |
How is Cash and Bank of NATCO PHARMA Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,176 Cr | 128.36 | |
| Mar2024 | ₹953 Cr | 74.43 | |
| Mar2023 | ₹546 Cr | 165.07 | |
| Mar2022 | ₹206 Cr | -27.30 | |
| Mar2021 | ₹284 Cr | - | |
Compare Cash and Bank of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹17,521.4 Cr | 2.1% | 3.6% | 17.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 2.1% |
3.6% |
17.4% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses